These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26208995)

  • 21. Dental units as infection sources of Pseudomonas aeruginosa.
    Barben J; Schmid J
    Eur Respir J; 2008 Oct; 32(4):1122-3. PubMed ID: 18827162
    [No Abstract]   [Full Text] [Related]  

  • 22. Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis.
    Geddes DM
    Lancet; 2001 Aug; 358(9281):522-3. PubMed ID: 11520516
    [No Abstract]   [Full Text] [Related]  

  • 23. Transmission of Pseudomonas cepacia by social contact in cystic fibrosis.
    Smyth A; Heaf D; Corkill J; Hart T; Sisson P; Freeman R
    Lancet; 1993 Aug; 342(8868):434-5. PubMed ID: 7688061
    [No Abstract]   [Full Text] [Related]  

  • 24. Transmission of Pseudomonas cepacia among cystic fibrosis patients.
    Millar-Jones L; Paull A; Saunders Z; Goodchild MC
    Lancet; 1992 Aug; 340(8817):491. PubMed ID: 1380626
    [No Abstract]   [Full Text] [Related]  

  • 25. To cohort or not to cohort: how transmissible is Pseudomonas aeruginosa?
    Ramsey BW
    Am J Respir Crit Care Med; 2002 Oct; 166(7):906-7. PubMed ID: 12359642
    [No Abstract]   [Full Text] [Related]  

  • 26. Complex Pseudomonas population structure in cystic fibrosis airway infections.
    Workentine M; Surette MG
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1581-3. PubMed ID: 21693712
    [No Abstract]   [Full Text] [Related]  

  • 27. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp.
    Ojeniyi B; Frederiksen B; Hoiby N
    Pediatr Pulmonol; 2000 Mar; 29(3):177-81. PubMed ID: 10686037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
    Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
    Jones AM; Dodd ME; Govan JR; Doherty CJ; Smith CM; Isalska BJ; Webb AK
    Am J Respir Crit Care Med; 2005 Feb; 171(3):257-60. PubMed ID: 15542795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers.
    LiPuma JJ; Mortensen JE; Dasen SE; Edlind TD; Schidlow DV; Burns JL; Stull TL
    J Pediatr; 1988 Nov; 113(5):859-62. PubMed ID: 2903229
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pseudomonas aeruginosa and cystic fibrosis. Risks of contamination].
    Mouterde O; Massot J; Vassal S
    Arch Fr Pediatr; 1992 May; 49(5):476-7. PubMed ID: 1530450
    [No Abstract]   [Full Text] [Related]  

  • 33. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics.
    Schmid J; Ling LJ; Leung JL; Zhang N; Kolbe J; Wesley AW; Mills GD; Brown PJ; Jones DT; Laing RT; Pattemore PK; Taylor DR; Grimwood K
    Eur Respir J; 2008 Dec; 32(6):1583-90. PubMed ID: 18715877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.
    Govan JR
    J R Soc Med; 2000; 93 Suppl 38(Suppl 38):40-5. PubMed ID: 10911818
    [No Abstract]   [Full Text] [Related]  

  • 35. The epidemiological significance of Pseudomonas aeruginosa in hospital sinks.
    Chadwick P
    Can J Public Health; 1976; 67(4):323-8. PubMed ID: 822937
    [No Abstract]   [Full Text] [Related]  

  • 36. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
    Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
    J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.
    Aaron SD; Vandemheen KL; Ramotar K; Giesbrecht-Lewis T; Tullis E; Freitag A; Paterson N; Jackson M; Lougheed MD; Dowson C; Kumar V; Ferris W; Chan F; Doucette S; Fergusson D
    JAMA; 2010 Nov; 304(19):2145-53. PubMed ID: 21081727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients.
    VanDevanter DR; Van Dalfsen JM; Burns JL; Mayer-Hamblett N
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):151-4. PubMed ID: 26407415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.
    Wolz C; Kiosz G; Ogle JW; Vasil ML; Schaad U; Botzenhart K; Döring G
    Epidemiol Infect; 1989 Apr; 102(2):205-14. PubMed ID: 2495226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Airborne dissemination of transmissible bacterial species in cystic fibrosis.
    Jones AM
    Thorax; 2014 Aug; 69(8):690-1. PubMed ID: 24898016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.